134 related articles for article (PubMed ID: 38702131)
1. Sebaceous Neoplasm With Defective DNA Mismatch Repair.
Tekin B; Gupta S; Erickson LA
Mayo Clin Proc; 2024 May; 99(5):846-848. PubMed ID: 38702131
[No Abstract] [Full Text] [Related]
2. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
[TBL] [Abstract][Full Text] [Related]
3. [Female patient with Muir-Torre syndrome].
Negraszus N; Jöhrens K; Bertelmann E
Ophthalmologe; 2010 Nov; 107(11):1059-62. PubMed ID: 20393721
[TBL] [Abstract][Full Text] [Related]
4. Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse?
Kim RH; Nagler AR; Meehan SA
J Am Acad Dermatol; 2016 Nov; 75(5):1078-1079. PubMed ID: 27745640
[No Abstract] [Full Text] [Related]
5. p53 staining correlates with tumor type and location in sebaceous neoplasms.
Shalin SC; Sakharpe A; Lyle S; Lev D; Calonje E; Lazar AJ
Am J Dermatopathol; 2012 Apr; 34(2):129-35; quiz 136-8. PubMed ID: 22441365
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of universal immunohistochemical screening of sebaceous neoplasms in a service setting.
Schon K; Rytina E; Drummond J; Simmonds J; Abbs S; Sandford R; Tischkowitz M
Clin Exp Dermatol; 2018 Jun; 43(4):410-415. PubMed ID: 29333623
[TBL] [Abstract][Full Text] [Related]
7. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.
Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F
Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167
[TBL] [Abstract][Full Text] [Related]
8. Sebaceous neoplasms and the immunoprofile of mismatch-repair proteins as a screening target for syndromic cases.
Boennelycke M; Thomsen BM; Holck S
Pathol Res Pract; 2015 Jan; 211(1):78-82. PubMed ID: 25457183
[TBL] [Abstract][Full Text] [Related]
9. An Intrapatient Concordance Study of Mismatch Repair Protein Immunohistochemical Staining Patterns in Patients With Muir-Torre Syndrome.
Nguyen CV; Gaddis KJ; Stephens MR; Seykora JT; Chu EY
JAMA Dermatol; 2020 Jun; 156(6):676-680. PubMed ID: 32267475
[TBL] [Abstract][Full Text] [Related]
10. A novel germline mutation in the hMLH1 DNA mismatch repair gene in a patient with an isolated cystic sebaceous tumor.
Kruse R; Rütten A; Malayeri HR; Günzl HJ; Friedl W; Propping P
J Invest Dermatol; 1999 Jan; 112(1):117-8. PubMed ID: 9886275
[No Abstract] [Full Text] [Related]
11. Muir-Torre syndrome: Diagnostic and screening guidelines.
Jones B; Oh C; Mangold E; Egan CA
Australas J Dermatol; 2006 Nov; 47(4):266-9. PubMed ID: 17034469
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability and mismatch repair protein expression in sebaceous tumors, keratocanthoma, and basal cell carcinomas with sebaceous differentiation in Muir-Torre syndrome.
Ponti G; Longo C
J Am Acad Dermatol; 2013 Mar; 68(3):509-10. PubMed ID: 23394915
[No Abstract] [Full Text] [Related]
13. Sebaceous Neoplasms.
Flux K
Surg Pathol Clin; 2017 Jun; 10(2):367-382. PubMed ID: 28477886
[TBL] [Abstract][Full Text] [Related]
14. Sebaceous Neoplasms With Rippled, Labyrinthine/Sinusoidal, Petaloid, and Carcinoid-Like Patterns: A Study of 57 Cases Validating Their Occurrence as a Morphological Spectrum and Showing No Significant Association With Muir-Torre Syndrome or DNA Mismatch Repair Protein Deficiency.
Wiedemeyer K; Kyrpychova L; Işikci ÖT; Spagnolo DV; Kutzner H; Rütten A; Fernandez-Figueras MT; Denisjuk N; Suster S; Pavlovsky M; Petersson F; Michal M; Lee J; Kerl K; Kazakov DV
Am J Dermatopathol; 2018 Jul; 40(7):479-485. PubMed ID: 29924747
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
[TBL] [Abstract][Full Text] [Related]
16. A case of multiple sebaceous epithelioma: analysis of microsatellite instability.
Ueda M; Wang Y; Sugimura H; Tamura S; Kondoh M; Ichihashi M
J Dermatol; 1999 Mar; 26(3):178-82. PubMed ID: 10209926
[TBL] [Abstract][Full Text] [Related]
17. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
[TBL] [Abstract][Full Text] [Related]
18. TERT promoter mutation in sebaceous neoplasms.
Muñoz-Jiménez MT; Blanco L; Ruano Y; Carrillo R; Santos-Briz Á; Riveiro-Falkenbach E; Requena L; Kutzner H; Garrido MC; Rodríguez-Peralto JL
Virchows Arch; 2021 Sep; 479(3):551-558. PubMed ID: 33768319
[TBL] [Abstract][Full Text] [Related]
19. BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis.
Cornejo KM; Hutchinson L; Deng A; Tomaszewicz K; Welch M; Lyle S; Dresser K; Cosar EF
Hum Pathol; 2014 Jun; 45(6):1213-20. PubMed ID: 24767862
[TBL] [Abstract][Full Text] [Related]
20. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.
Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T
J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
